Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

MDS Nordion opens radiopharmaceutical production facility for PET imaging

MDS Nordion : 01 June, 2009  (Company News)
MDS Nordion opens a facility in Fleurus, Belgium for the production of Glucotrace (Fluorodeoxyglucose), a radiopharmaceutical used in positron emission tomography (PET) imaging.
PET imaging produces a three-dimensional image, or picture, of functional processes in the body, such as brain activity, and is a highly accurate and effective method of diagnosing disease and managing patient therapy. MDS Nordion's new facility will provide a timely supply of Glucotrace to hospitals throughout Belgium, France, The Netherlands, Luxembourg and Germany.

'Customers count on MDS Nordion for leadership, quality products and customized services,' said Steve West, President MDS Nordion. 'Our investment in this facility further demonstrates our commitment to address the growing demand for PET diagnostic imaging in targeted European regions, and provides the medical community greater service for their future patient care.'

The PET imaging market is the most rapidly growing area of nuclear medicine and procedures. Statistics from a recent Medical Options survey indicates PET examinations are on a rapid rise in Europe, and are expected to grow at a compound annual rate of approximately 20 percent through 2012. To help meet increasing demand, this state-of-the-art, Good Manufacturing Practice (GMP) production facility will have three daily production runs and a customer service team available 24 hours a day, seven days a week.

'PET imaging is effective because it allows early detection of tumours, as well as assessment of therapeutic strategies,' said Professor Roland Hustinx, Nuclear Medicine Department, CHU - Universite de Liege. 'In particular, MDS Nordion's new facility will provide another source of supply of Glucotrace to existing and new medical facilities, thereby increasing the ability of health-care practitioners to conduct this critical type of imaging.'
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo